| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Anupam Raina, Sameehan Mahajani, Mathias Bähr, Sebastian Kügle. Neuronal Trans-differentiation by Transcription Factors Ascl1 and Nurr1: Induction of a Dopaminergic Neurotransmitter Phenotype in Cortical GABAergic Neurons. Molecular neurobiology. vol 57. issue 1. 2020-10-07. PMID:31317490. |
however, neurotransmitter phenotype plasticity critically depends on the differentiation history of the template neurons, which can result in relatively low yields of dopaminergic neurons. |
2020-10-07 |
2023-08-13 |
rat |
| Kenneth Blum, Peter K Thanos, Marlene Oscar-Berman, Marcelo Febo, David Baron, Rajendra D Badgaiyan, Eliot Gardner, Zsolt Demetrovics, Claudia Fahlke, Brett C Haberstick, Kristina Dushaj, Mark S Gol. Dopamine in the Brain: Hypothesizing Surfeit or Deficit Links to Reward and Addiction. Journal of reward deficiency syndrome. vol 1. issue 3. 2020-10-01. PMID:27398406. |
vulnerability to addiction and relapse may be the result of the cumulative effects of dopaminergic and other neurotransmitter genetic variants and elevated stress levels. |
2020-10-01 |
2023-08-13 |
Not clear |
| Pichet Termsarasab, Thananan Thammongkolchai, Steven J Fruch. Medical treatment of dystonia. Journal of clinical movement disorders. vol 3. 2020-10-01. PMID:28031858. |
we review the medical treatment of dystonia, focusing on three major neurotransmitter systems: cholinergic, gabaergic and dopaminergic. |
2020-10-01 |
2023-08-13 |
Not clear |
| Anand Venkatraman, Brian L Edlow, Mary Helen Immordino-Yan. The Brainstem in Emotion: A Review. Frontiers in neuroanatomy. vol 11. 2020-10-01. PMID:28337130. |
finally, the brainstem is home to a group of modulatory neurotransmitter pathways, such as those arising from the raphe nuclei (serotonergic), ventral tegmental area (dopaminergic) and locus coeruleus (noradrenergic), which form a modulatory network that coordinates interactions between the ascending and descending networks. |
2020-10-01 |
2023-08-13 |
human |
| Ahmed Al-Qassabi, Seyed-Mohammad Fereshtehnejad, Ronald B Postum. Sleep Disturbances in the Prodromal Stage of Parkinson Disease. Current treatment options in neurology. vol 19. issue 6. 2020-10-01. PMID:28466429. |
disturbances in serotonergic, cholinergic, dopaminergic, and glutamatergic neurotransmitter systems have made sleep disorders potential candidates for prodromal pd. |
2020-10-01 |
2023-08-13 |
Not clear |
| Christian Pifl, Harald Reither, Natalia Lopez-Gonzalez Del Rey, Carmen Cavada, Jose A Obeso, Javier Bles. Early Paradoxical Increase of Dopamine: A Neurochemical Study of Olfactory Bulb in Asymptomatic and Symptomatic MPTP Treated Monkeys. Frontiers in neuroanatomy. vol 11. 2020-10-01. PMID:28611598. |
olfactory bulb (ob) pathology shows an increased number of olfactory dopaminergic cells, protein aggregates and dysfunction of neurotransmitter systems. |
2020-10-01 |
2023-08-13 |
monkey |
| Ansley Stanfill, Claire Simpson, Paula Sherwood, Samuel Poloyac, Elizabeth Crago, Hyungsuk Kim, Yvette Conle. A pilot study on the impact of dopamine, serotonin, and brain-derived neurotrophic factor genotype on long-term functional outcomes after subarachnoid hemorrhage. SAGE open medicine. vol 5. 2020-10-01. PMID:28894586. |
many that survive an aneurysmal subarachnoid hemorrhage experience lasting physical disability, which might be improved by medications with effects on the dopaminergic, serotonergic, and brain-derived neurotrophic factor neurotransmitter systems. |
2020-10-01 |
2023-08-13 |
Not clear |
| Luiza R Nazario, Rosane S da Silva, Carla D Bona. Targeting Adenosine Signaling in Parkinson's Disease: From Pharmacological to Non-pharmacological Approaches. Frontiers in neuroscience. vol 11. 2020-10-01. PMID:29217998. |
the formulation of multi-targeted drugs, using adenosine receptor antagonists and other neurotransmitter systems than the dopaminergic one as targets, have been receiving attention since parkinson's disease presents a complex biological impact. |
2020-10-01 |
2023-08-13 |
Not clear |
| Aleksander H Erga, Ingvild Dalen, Anastasia Ushakova, Janete Chung, Charalampos Tzoulis, Ole Bjørn Tysnes, Guido Alves, Kenn Freddy Pedersen, Jodi Maple-Grøde. Dopaminergic and Opioid Pathways Associated with Impulse Control Disorders in Parkinson's Disease. Frontiers in neurology. vol 9. 2020-10-01. PMID:29541058. |
icds are closely associated with dopaminergic therapy, and genetic polymorphisms in several neurotransmitter pathways may increase the risk of addictive behaviors in pd. |
2020-10-01 |
2023-08-13 |
Not clear |
| Kazushige Mizoguchi, Yasushi Ikarash. Cellular Pharmacological Effects of the Traditional Japanese Kampo Medicine Yokukansan on Brain Cells. Frontiers in pharmacology. vol 8. 2020-09-30. PMID:28979206. |
regarding the pharmacological mechanisms underlying its efficacy, we recently reviewed the multiple effects of yks on the neurotransmitter systems (e.g., glutamatergic, serotonergic, dopaminergic, cholinergic, gabaergic, and adrenergic neurotransmission) in various brain regions that are related to the psychological, emotional, cognitive, or memory functions. |
2020-09-30 |
2023-08-13 |
Not clear |
| Cristy Phillips, Atoossa Fahim. Immune and Neuroprotective Effects of Physical Activity on the Brain in Depression. Frontiers in neuroscience. vol 12. 2020-09-30. PMID:30093853. |
physical activity optimizes the stress response, neurotransmitter level and function (e.g., serotonergic, noradrenergic, dopaminergic, and glutamatergic), myokine production (e.g., interleukin-6), transcription factor levels and correlates [e.g., peroxisome proliferator-activated receptor c coactivator-1α [pgc-1α], mitochondrial density, nitric oxide pathway activity, ca |
2020-09-30 |
2023-08-13 |
Not clear |
| Fatemeh N Emamzadeh, Andrei Surgucho. Parkinson's Disease: Biomarkers, Treatment, and Risk Factors. Frontiers in neuroscience. vol 12. 2020-09-30. PMID:30214392. |
dopamine is a neurotransmitter involved in movement, motivation, memory, and other functions; its level is decreased in pd brain as a result of dopaminergic cell death. |
2020-09-30 |
2023-08-13 |
Not clear |
| Pavel Filip, Pavla Linhartová, Pavlína Hlavatá, Rastislav Šumec, Marek Baláž, Martin Bareš, Tomáš Kašpáre. Disruption of Multiple Distinctive Neural Networks Associated With Impulse Control Disorder in Parkinson's Disease. Frontiers in human neuroscience. vol 12. 2020-09-30. PMID:30519167. |
ergo, our results present a refinement and synthesis of gradually developing ideas about the nature of impulsive control disorder in parkinson's disease-an umbrella term encompassing various behavioral deviations related to distinct neuronal networks and presumably neurotransmitter systems, which greatly exceed the previously envisioned dopaminergic pathways as the only culprit. |
2020-09-30 |
2023-08-13 |
Not clear |
| Rafael Gonzalo-Gobernado, Diana Reimers, María José Casarejos, Lucía Calatrava Ferreras, Manuela Vallejo-Muñoz, Adriano Jiménez-Escrig, Juan José Diaz-Gil, Gonzalo M Ulzurrun de Asanza, Eulalia Bazá. Liver Growth Factor Induces Glia-Associated Neuroprotection in an In Vitro Model of Parkinson´s Disease. Brain sciences. vol 10. issue 5. 2020-09-28. PMID:32455921. |
parkinson's disease is a neurodegenerative disorder characterized by the progressive death of dopaminergic (da) neurons in the substantia nigra (sn), which leads to a loss of the neurotransmitter dopamine in the basal ganglia. |
2020-09-28 |
2023-08-13 |
rat |
| Sudip Dhakal, Ian Macreadi. Tyramine and Amyloid Beta 42: A Toxic Synergy. Biomedicines. vol 8. issue 6. 2020-09-28. PMID:32486277. |
implicated in various diseases including parkinson's disease, huntington's disease, migraines, schizophrenia and increased blood pressure, tyramine plays a crucial role as a neurotransmitter in the synaptic cleft by reducing serotonergic and dopaminergic signaling through a trace amine-associated receptor (taar1). |
2020-09-28 |
2023-08-13 |
Not clear |
| O Yu Fedorenko, S A Ivanov. [A new look at the genetics of neurocognitive deficits in schizophrenia]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. vol 120. issue 8. 2020-09-16. PMID:32929943. |
the article presents current literature data on genetic studies of neurocognitive deficit in schizophrenia, including the genes of neurotransmitter systems (dopaminergic, glutamatergic, and serotonergic); genes analyzed in genome-wide association studies (gwas), as well as other genetic factors related to the pathophysiological mechanisms underlying schizophrenia and neurocognitive disorders. |
2020-09-16 |
2023-08-13 |
Not clear |
| P Marcos, R Coveña. Neuroanatomical relationship between the cholinergic and tachykininergic systems in the adult human brainstem: An immunohistochemical study. Journal of chemical neuroanatomy. vol 102. 2020-09-14. PMID:31585148. |
these interactions might participate in motor regulation or in limbic pathways as well as influence on other neurotransmitter systems such as the dopaminergic system. |
2020-09-14 |
2023-08-13 |
human |
| Kevin Gley, Eduard Murani, Fiete Haack, Nares Trakooljul, Manuela Zebunke, Birger Puppe, Klaus Wimmers, Siriluck Ponsuksil. Haplotypes of coping behavior associated QTL regions reveal distinct transcript profiles in amygdala and hippocampus. Behavioural brain research. vol 372. 2020-09-10. PMID:31202863. |
we discovered candidate genes in regions detected by genome-wide association study including arrb2, adrbk2, thrb, nek7 and acvr2b, which relate to dopaminergic and other monoaminergic neurotransmitter systems, neuroimmunomodulation, neuroinflammation and gaba-ergic neurotransmission. |
2020-09-10 |
2023-08-13 |
Not clear |
| Rong Yang, Meng-Qi Zhang, Ying Xue, Rui Yang, Mi-Mi Tan. Dietary of n-3 polyunsaturated fatty acids influence neurotransmitter systems of rats exposed to unpredictable chronic mild stress. Behavioural brain research. vol 376. 2020-09-03. PMID:31445977. |
high-performance liquid chromatography coupled to tandem mass spectrometry (hplc-ms/ms) was used to quantify the levels of neurotransmitters and their metabolites involved in serotonergic, dopaminergic, noradrenergic, gabaergic neurotransmitter systems in hippocampus and prefrontal cortex. |
2020-09-03 |
2023-08-13 |
rat |
| SeungJu Jackie Oh, Xiaoduo Fa. The Possible Role of the Angiotensin System in the Pathophysiology of Schizophrenia: Implications for Pharmacotherapy. CNS drugs. vol 33. issue 6. 2020-08-28. PMID:30993607. |
with a greater understanding of how ras inhibition directly modulates neurotransmitter balance in the brain, it is possible that compounds with ras-inhibiting properties could be used to optimize physiological levels of glutamate, dopamine, and gaba, and the balance among the three neurotransmitters, analogously to how antipsychotic medications mediate the dopaminergic pathways. |
2020-08-28 |
2023-08-13 |
Not clear |